×




Zantac (A) Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Zantac (A) case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Zantac (A) case study is a Harvard Business School (HBR) case study written by Reinhard Angelmar, Christian Pinson. The Zantac (A) (referred as “Pharmaceutical Category” from here on) case study provides evaluation & decision scenario in field of Sales & Marketing. It also touches upon business topics such as - Value proposition, National competitiveness.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Zantac (A) Case Study


The cases describe the development, worldwide launch, and subsequent marketing of a new pharmaceutical product which, although it represented only a slight improvement over the category pioneer, not only became the leading product in its category, but the largest prescription pharmaceutical product overall worldwide. Its success propelled Glaxo, the company which developed and marketed the product, from the minor leagues to the top ranks in the pharmaceutical industry.


Case Authors : Reinhard Angelmar, Christian Pinson

Topic : Sales & Marketing

Related Areas : National competitiveness




Calculating Net Present Value (NPV) at 6% for Zantac (A) Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10006840) -10006840 - -
Year 1 3451135 -6555705 3451135 0.9434 3255788
Year 2 3976994 -2578711 7428129 0.89 3539511
Year 3 3965191 1386480 11393320 0.8396 3329251
Year 4 3232205 4618685 14625525 0.7921 2560209
TOTAL 14625525 12684758




The Net Present Value at 6% discount rate is 2677918

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Internal Rate of Return
2. Payback Period
3. Profitability Index
4. Net Present Value

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Timing of the expected cash flows – stockholders of Pharmaceutical Category have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.
2. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Pharmaceutical Category shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.






Formula and Steps to Calculate Net Present Value (NPV) of Zantac (A)

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Sales & Marketing Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Pharmaceutical Category often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Pharmaceutical Category needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10006840) -10006840 - -
Year 1 3451135 -6555705 3451135 0.8696 3000987
Year 2 3976994 -2578711 7428129 0.7561 3007179
Year 3 3965191 1386480 11393320 0.6575 2607177
Year 4 3232205 4618685 14625525 0.5718 1848024
TOTAL 10463367


The Net NPV after 4 years is 456527

(10463367 - 10006840 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10006840) -10006840 - -
Year 1 3451135 -6555705 3451135 0.8333 2875946
Year 2 3976994 -2578711 7428129 0.6944 2761801
Year 3 3965191 1386480 11393320 0.5787 2294671
Year 4 3232205 4618685 14625525 0.4823 1558741
TOTAL 9491159


The Net NPV after 4 years is -515681

At 20% discount rate the NPV is negative (9491159 - 10006840 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Pharmaceutical Category to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Pharmaceutical Category has a NPV value higher than Zero then finance managers at Pharmaceutical Category can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Pharmaceutical Category, then the stock price of the Pharmaceutical Category should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Pharmaceutical Category should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

Understanding of risks involved in the project.

What will be a multi year spillover effect of various taxation regulations.

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

What can impact the cash flow of the project.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Zantac (A)

References & Further Readings

Reinhard Angelmar, Christian Pinson (2018), "Zantac (A) Harvard Business Review Case Study. Published by HBR Publications.


J Sainsbury SWOT Analysis / TOWS Matrix

Services , Retail (Grocery)


HTG Molecular Diagnostics SWOT Analysis / TOWS Matrix

Technology , Scientific & Technical Instr.


Citic Helicop A SWOT Analysis / TOWS Matrix

Transportation , Misc. Transportation


Cymabay Therapeu SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


Suprema HQ SWOT Analysis / TOWS Matrix

Technology , Computer Peripherals


Nanosave Tech SWOT Analysis / TOWS Matrix

Energy , Oil & Gas Operations


Beijing eGOVA SWOT Analysis / TOWS Matrix

Technology , Software & Programming


Mega Uranium SWOT Analysis / TOWS Matrix

Basic Materials , Metal Mining


Hunt Finance SWOT Analysis / TOWS Matrix

Financial , Misc. Financial Services


Daejan SWOT Analysis / TOWS Matrix

Services , Real Estate Operations


Weir Group SWOT Analysis / TOWS Matrix

Capital Goods , Misc. Capital Goods


Jubilant Industries Ltd SWOT Analysis / TOWS Matrix

Basic Materials , Chemicals - Plastics & Rubber